AstraZeneca on Tuesday presented data from the AURA3 trial that showed how Tagrisso…
Novartis on Tuesday announced results at International Association for the Study of Lung Cancer
Celyad has presented new data from the Phase I trial of NKR-2 in patients …
Noxxon Pharma has presented data of the role of CXCL12
ValiRx Plc said on Thursday that that it has begun with commissioning a second clinical testing for cancer drug VAL401.
Innate Pharma SA’s test of monalizumab, an anti-NKG2A antibody partnered with AstraZeneca, as a single agent in patients with advanced gynecologic malignancies.
Pfizer and Merck wait FDA’s approval for their skin cancer drug Avelumab